Document is current
Any future updates will be listed below
-
Authors
Chen, Jiaxuan
Liao, Shuzhen
Lun, Jiaqi
Lu, Xing
Huang, Bitang
Liu, Xiaoxian
Xu, Xiaowei
Yang, Lawei
Guo, Fengbiao
You, Liuyong
Xiao, Haiyan
Liu, Hua-Feng
Pan, Qingjun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82070757, 82270770)
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 5 August 2025
First Online: 22 August 2025
Declarations
:
: Based on the modified SLE classification criteria formulated by the American College of Rheumatology in 1997, 48 patients with SLE were enrolled in this study at the Department of Nephrology between September 2020 and November 2024. This study was approved by the Affiliated Hospital of Guangdong Medical University’s ethics committee (Approval no. YJYS2020107). Written informed consent was obtained from all the patients. Mcpt8flox/flox, CAGGCre−ERTM, Mcpt8flox/flox, and NKG mice were obtained from Cyagen Biosciences (License No. SCXK (Yue) 2020–0055). The maintenance of these mice was approved by the Ethics Committee for Experimental Animals of the Affiliated Hospital of Guangdong Medical University (Approval no. GDY2002081). All experiments were conducted under the national animal welfare guidelines.
: All authors read and approved the manuscript.
: The authors declare no competing interests.
